With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Therapeutic Targeting of Childhood Leukemia by Pharmacological Inhibition of Proteolytic Cleavage of MLL1||Northwestern University (Illinois) / Zibo Zhao, PhD||Young Investigator Grants||2018||Illinois|
|Epigenetic Targeted Therapy and Resistance in Pediatric Rhabdoid Tumor||Ann & Robert H. Lurie Children's Hospital of Chicago / Rintaro Hashizume, MD/PhD||Reach Grants||2018||Illinois|
|Accessing Combinatorial Effect of PARP Inhibitor with DNA Damaging Agent in Rhabdomyosarcoma at Single Cell Resolution||Massachusetts General Hospital / Chuan Yan, PhD||Young Investigator Grants||2018||Massachusetts|
|MYC-driven Core Regulatory Circuits in Neuroblastoma||Dana-Farber Cancer Institute / Mark Zimmerman, PhD||Young Investigator Grants||2018||Massachusetts|
|Divergent Core Transcriptional Regulatory Circuitries to Highlight Context-Specific Vulnerabilities in AML||Dana-Farber Cancer Institute / Maxim Pimkin, MD/PhD||Young Investigator Grants||2018||Massachusetts|
|Targeting the Metabolic Drivers of Chemo Resistance in Acute Myeloid Leukemia||Harvard University / Nick van Gastel, PhD||Young Investigator Grants||2018||Massachusetts|
|Modeling GATA2 Associated MDS/AML Predisposition Syndrome Using Color-Barcoding and Mutagenesis in Zebrafish||Dana-Farber Cancer Institute / Serine Avagyan, PhD||Young Investigator Grants||2018||Massachusetts|
|Olfactory Ensheathing Cells for Pediatric Glioma Gene/Cell Therapy||Massachusetts General Hospital / Bakhos Tannous, PhD||Innovation Grants||2018||Massachusetts|
|Targeting Oncogenic RAS in Pediatric Leukemia||Dana-Farber Cancer Institute / Loren Walensky, MD/PhD||Innovation Grants||2018||Massachusetts|
|Identifying a Therapeutic Partner for TAK228 for Pediatric Phase II Brain Tumor Studies||The Johns Hopkins University School of Medicine / Eric H. Raabe, MD/PhD||Reach Grants||2018||Maryland|